Restoring the Multiple Sclerosis Associated Imbalance of Gut Indole Metabolites Promotes Remyelination and Suppresses Neuroinflammation
2024

Restoring Gut Metabolites in Multiple Sclerosis

Sample size: 10 publication 10 minutes Evidence: moderate

Author Information

Author(s): Jank Larissa, Singh Saumitra S., Lee Judy, Dhukhwa Asmita, Siavoshi Fatemeh, Joshi Deepika, Minney Veronica, Gupta Kanak, Ghimire Sudeep, Deme Pragney, Schoeps Vinicius A., Soman Karthik, Ladakis Dimitrios, Smith Matthew, Borkowski Kamil, Newman John, Baranzini Sergio E., Waubant Emmanuelle L., Fitzgerald Kathryn C., Mangalam Ashutosh, Haughey Norman, Kornberg Michael, Chamling Xitiz, Calabresi Peter A., Bhargava Pavan

Primary Institution: Johns Hopkins University School of Medicine

Hypothesis

Can oral supplementation of indole lactate (ILA) restore gut microbial balance and improve multiple sclerosis outcomes?

Conclusion

Oral ILA supplementation reduces neuroinflammation and promotes remyelination in multiple sclerosis models.

Supporting Evidence

  • ILA supplementation reduced peak and endpoint clinical scores in EAE mice.
  • ILA treatment decreased immune cell infiltration and reduced spinal cord demyelination.
  • Oral ILA supplementation increased the percentage of mature oligodendrocytes in the corpus callosum.

Takeaway

Giving a special gut metabolite called indole lactate to mice with multiple sclerosis helps them heal better and feel less sick.

Methodology

The study used two preclinical models of multiple sclerosis to assess the effects of ILA supplementation on neuroinflammation and remyelination.

Limitations

The high concentration of ILA required for effects in vitro may not reflect physiological conditions.

Statistical Information

P-Value

0.003

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1101/2024.10.27.620437

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication